The U.S. Food and Drug Administration (FDA) has classified Insulet Corporation’s recall of certain Omnipod insulin delivery ...

The U.S. Food and Drug Administration on Monday approved the expanded use of an automated insulin pump system to include those with type 2 diabetes. It's the first such system for use by people with ...

The US Food and Drug Administration (FDA) on Wednesday approved Medtronic’s artificial pancreas, known as the MiniMed 670G hybrid closed looped system, which is the first device approved in the US to ...

A device that combines an insulin patch pump with a continuous glucose monitor (CGM) in the same unit was shown to function in a small, early proof-of-concept study in people with type 1 diabetes (T1D ...

(WASHINGTON) — The U.S. Food and Drug Administration approved a first-of-its-kind insulin device today designed to automatically deliver insulin for type 1 diabetics. The device has many in the ...

Insulin manufacturers are extending brand-name market exclusivity by filing multiple new patents on their products' delivery devices, a new analysis suggests. The data come from the publicly available ...

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to ...

Significant advancements in diabetes management have marked the evolution of insulin delivery methods. Insulin was initially administered through injections, often leading to inconsistent blood ...

The Medicines and Healthcare products Regulatory Agency (MHRA) on Thursday said it has become aware of patients directly contacted by a manufacturer or other organization inviting them to trial a new ...

Medical device manufacturer Animas, a subsidiary of Johnson & Johnson, is warning diabetic patients who use its OneTouch Ping insulin pumps about security issues that could allow hackers to deliver ...